Phase 3 data show Tremfya improves scalp psoriasis in patients with skin of color

Patients with skin of color that suffer from scalp psoriasis saw significant improvement in their disease severity, scalp itch and quality of life outcomes when treated with Tremfya, according to newly released phase 3 results.
“Despite strides in health care equity, patients with nonwhite skin or diverse skin tones living with plaque and scalp psoriasis still encounter significant obstacles stemming from factors like race, socioeconomic disparities, implicit bias and limited awareness of how the disease can present differently in people with nonwhite skin or diverse skin tones,”

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart